In peripheral biomarker studies, AD patients commonly exhibit elevated serum ferritin and reduced levels of soluble transferrin receptor (sTfR), suggesting impaired systemic iron utilization (Chatterjee et al., 2023). The gene discussed is TFRC; the disease is Alzheimer disease.